Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years.
Dredze LM, Friger M, Ariad S, Koretz M, Delgado B, Shaco-Levy R, Tokar M, Bayme M, Agassi R, Rosenthal M, Dyomin V, Belochitski O, Libson S, Mizrahi T, Geffen DB. Dredze LM, et al. Among authors: koretz m. Breast Cancer Res Treat. 2022 Jun;193(3):597-612. doi: 10.1007/s10549-022-06598-0. Epub 2022 Apr 22. Breast Cancer Res Treat. 2022. PMID: 35451732
The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy.
Geffen DB, Abu-Ghanem S, Sion-Vardy N, Braunstein R, Tokar M, Ariad S, Delgado B, Bayme M, Koretz M. Geffen DB, et al. Among authors: koretz m. Ann Oncol. 2011 Nov;22(11):2381-2386. doi: 10.1093/annonc/mdq769. Epub 2011 Mar 1. Ann Oncol. 2011. PMID: 21363879 Free article.
Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a 'switching' policy in postmenopausal patients after initial tamoxifen.
Geffen DB, Tokar M, Abu-Ghanem S, Braunstein R, Koretz M, Amir N, Delgado B, Sion-Vardi N, Ariad S, Lazarev I. Geffen DB, et al. Among authors: koretz m. Oncology. 2013;85(3):145-52. doi: 10.1159/000353978. Epub 2013 Aug 28. Oncology. 2013. PMID: 23988814
Small cell carcinoma of the breast: case report.
Shaco-Levy R, Dyomin V, Kachko L, Sion-Vardy N, Geffen DB, Koretz M. Shaco-Levy R, et al. Among authors: koretz m. Eur J Gynaecol Oncol. 2007;28(2):142-4. Eur J Gynaecol Oncol. 2007. PMID: 17479680 Review.
49 results